HEATHER MYCHAK: Open Payments
NPI 1831447960 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 90 payments from 16 companies in 2025. Trend: 2023 $2,161 · 2024 $2,123 · 2025 $1,749
Food & beverage: $1,749
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $441 |
| ABBVIE INC. | 12 | $237 |
| Amgen Inc. | 13 | $201 |
| Galderma Laboratories, L.P. | 11 | $187 |
| Lilly USA, LLC | 9 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $83 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| UCB, Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| LEO Pharma Inc. | 2 | $47 |
Products named: TREMFYA, Otezla, SKYRIZI, NEMLUVIO, TALTZ, DUPIXENT, Bimzelx, COSENTYX.
Industry payments across PA — which companies pay providers there.
